The effect of using post-exposure prophylaxis to lower transmission risk

Twitter

  • Greece: Five (of 26) women in mass HIV criminalisation "sex worker" case acquitted http://t.co/LnDGFZJrfV 20 Mar 2013
  • US: Kansas to repeal ban on quarantining people with HIV, allow forced HIV testing following bodily fluids exposure http://t.co/jFZsLeD4Wg 20 Mar 2013
  • US: Illinois cop accused of HIV non-disclosure to be prosecuted under old unscientific HIV-specific law http://t.co/uZka8cQvTE #HIVisnocrime 18 Mar 2013
  • Canada: Police training and guidelines in criminal HIV non-disclosure cases urgently required http://t.co/twsGT55EBl @AIDSLAW #HIVCan 14 Mar 2013
  • Germany: National AIDS Council releases powerful policy statement on HIV criminalisation http://t.co/0vpT4r4kui #HIVisnocrime 13 Mar 2013
  • US: New study to explore effects of HIV criminalisation on health department policies and programmes http://t.co/S2qVzCXSuy 13 Mar 2013
  • UK: New research calls for better guidance for HIV service providers on criminal law, confidentiality and ethics http://t.co/0GdgIvxgQV 07 Mar 2013
  • New UK report from @SigmaResearch1 finds #HIV #criminalisation impact on healthcare workers and service providers http://t.co/85aCJmytz3 28 Feb 2013
  • US: HIV Experts Urge Minnesota Supreme Court to Consider the Science of HIV Transmission http://t.co/nNUJeEWymF 24 Feb 2013
  • @aidsactioneurop Thank you very much for publicising this important initiative. 20 Feb 2013
  • The latest HIV Justice Newletter is out today, on the one year anniversary of the Oslo Declaration http://t.co/W8ovLJG6 13 Feb 2013
  • UK: Updated guidance on HIV transmission, the law and the work of the clinical team now published http://t.co/E77K5uPd 13 Feb 2013
  • Nigeria: Advocates successfully argue for removal of HIV criminalisation clause from draft HIV Anti-Discrimination Act http://t.co/yZl6EMmU 13 Feb 2013
  • Australia: NSW man with HIV who "spat blood" on arresting officer pleads guilty to assaulting and intimidating police http://t.co/dxg7WUeL 12 Feb 2013

Post-exposure prophylaxis (PEP) is a short course of HIV medication, usually a combination of two or three drugs, that is prescribed for 28 days. The purpose of PEP is to prevent the small amount of HIV that may have entered the body from taking over enough cells to establish lasting infection.

PEP was first used by healthcare workers. In certain settings, most commonly in high-income countries, access has been expanded to other people who may be exposed to HIV occupationally. In some settings, PEP is also recommended for people with probable non-occupational exposure to HIV as a result of sexual assault, condom failure or unprotected sex.

Two key studies have provided evidence that PEP can prevent HIV infection: one study showed that antiretrovirals prevented monkeys from being infected with a virus similar to HIV, known as SIV (simian immunodeficiency virus); and a second study found that a single antiretroviral taken within 24 hours of needlestick exposure reduced the risk of HIV infection among healthcare workers by 80%.1 For ethical and practical reasons, it is not feasible to conduct a randomised trial that might provide stronger evidence of PEP’s effectiveness.

References

  1. Cardo DM et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 337: 1485-1490, 1997

HIV Justice
Network

RSS Feed

A writer and advocate on a range of HIV-related issues, Edwin has a particular specialism in HIV and the criminal law. He works with national and international HIV organisations, including the International AIDS Society, GNP+ and UNAIDS, as well having as a long association with NAM as a writer on this topic and as the former editor of HIV Treatment Update. To visit Edwin's blog and respond to posts click here.

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.